Background: Despite changing federal regulations for providing telehealth services and
provision of controlled substances during the COVID-19 pandemic, there is little guidance …

The coronavirus disease pandemic of 2019 (COVID-19) has created significant economic
and societal burden, with mortality currently exceeding 615,000 and millions of others …

Objective The COVID-19 pandemic has transformed care delivery for patients with opioid
use disorder (OUD); however, little is known about the experiences of front-line clinicians in …

Background Changes in federal policy during the COVID-19 pandemic allowing for the use
of telemedicine to treat opioid use disorder (OUD) have facilitated innovative strategies to …

Background COVID-19 has exacerbated income inequality, structural racism, and social
isolation—issues that drive addiction and have previously manifested in the epidemic of …

Background The COVID-19 pandemic had the potential to severely disrupt the delivery of
methadone and buprenorphine, as social distancing and other public health regulations …

Objectives We aimed to assess the feasibility of using a telemedicine bridge clinic model as
a low-barrier mechanism to initiate patients on medication treatment for opioid use disorder …

Background This study investigated the efficacy and safety of providing medication for opioid
use disorder (MOUD) and individualized telehealth in Kentucky, a state severely impacted …

Background: The COVID-19 pandemic resulted in a marked increase in telehealth for the
provision of primary care-based opioid use disorder (OUD) treatment. This mixed methods …

Abstract Background Opioid treatment programs (OTPs) serve as daily essential services for
people with opioid use disorder. This study seeks to identify modifications to operations and …